These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17607014)

  • 1. Eat dirt: CpG DNA and immunomodulation of asthma.
    Kline JN
    Proc Am Thorac Soc; 2007 Jul; 4(3):283-8. PubMed ID: 17607014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma.
    Gupta GK; Agrawal DK
    BioDrugs; 2010 Aug; 24(4):225-35. PubMed ID: 20623989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
    Fonseca DE; Kline JN
    Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.
    Kline JN; Krieg AM
    Drug News Perspect; 2008 Oct; 21(8):434-9. PubMed ID: 19034349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of asthma using CpG oligodeoxynucleotides.
    Kline JN
    Immunol Res; 2007; 39(1-3):279-86. PubMed ID: 17917072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma.
    Mousavi T; Salek Moghadam A; Falak R; Tebyanian M
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG oligodeoxynucleotides in asthma.
    Hussain I; Kline JN
    Curr Opin Investig Drugs; 2001 Jul; 2(7):914-8. PubMed ID: 11757790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
    Chu CY; Lee SC; Liu SS; Lin YM; Shen PC; Yu C; Lee KH; Zhao X; Lee JW
    Nucleic Acid Ther; 2011 Oct; 21(5):323-32. PubMed ID: 21916610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
    Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modulation of Toll-like signal path of allergic asthma by CpG-ODNs from Bordetella pertussis].
    Zhang BY; Chi S; Sun Y
    Yao Xue Xue Bao; 2011 Mar; 46(3):285-92. PubMed ID: 21626782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA.
    Krieg AM
    Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):181-8. PubMed ID: 11446594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
    Schlaepfer E; Audigé A; von Beust B; Manolova V; Weber M; Joller H; Bachmann MF; Kundig TM; Speck RF
    J Virol; 2004 Nov; 78(22):12344-54. PubMed ID: 15507621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides.
    Kline JN; Kitagaki K; Businga TR; Jain VV
    Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L170-9. PubMed ID: 12060574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
    Kline JN; Waldschmidt TJ; Businga TR; Lemish JE; Weinstock JV; Thorne PS; Krieg AM
    J Immunol; 1998 Mar; 160(6):2555-9. PubMed ID: 9510150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice.
    Kitagaki K; Businga TR; Kline JN
    Clin Exp Immunol; 2006 Feb; 143(2):249-59. PubMed ID: 16412048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of experimental asthma by mycobacterial protein combined with CpG requires a TLR9-dependent IFN-γ-CCR2 signalling circuit.
    Prado RQ; Bertolini TB; Piñeros AR; Gembre AF; Ramos SG; Silva CL; Borges MC; Bonato VL
    Clin Exp Allergy; 2015 Sep; 45(9):1459-71. PubMed ID: 25944185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of CpG oligodeoxynucleotides as immune adjuvants.
    Klinman DM; Currie D; Gursel I; Verthelyi D
    Immunol Rev; 2004 Jun; 199():201-16. PubMed ID: 15233736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis.
    Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC
    Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.
    Chikh G; de Jong SD; Sekirov L; Raney SG; Kazem M; Wilson KD; Cullis PR; Dutz JP; Tam YK
    Int Immunol; 2009 Jul; 21(7):757-67. PubMed ID: 19502586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.